Pasar al contenido principal

NANOMEDICINAS BASADAS EN NANOPARTICULAS PARA INMUNOTERAPIA EN CANCER Y ENFERMEDADES AUTOINMUNES.

PID2020-112685RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 12
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Iron oxide and iron oxyhydroxide nanoparticles impair SARS-CoV-2 infection of cultured cells

  • DeDiego, Marta L.
  • Portilla, Yadileiny
  • Daviu, Neus
  • López-García, Darío
  • Villamayor Coronado, Laura
  • Mulens-Arias, Vladimir
  • Ovejero, Jesús G.
  • Gallo-Cordova, Álvaro
  • Veintemillas-Verdaguer, S.
  • Morales, María Del Puerto
  • Barber, Domingo F.
Background Coronaviruses usually cause mild respiratory disease in humans but as seen recently, some human coronaviruses can cause more severe diseases, such as the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the global spread of which has resulted in the ongoing coronavirus pandemic. Results In this study we analyzed the potential of using iron oxide nanoparticles (IONPs) coated with biocompatible molecules like dimercaptosuccinic acid (DMSA), 3-aminopropyl triethoxysilane (APS) or carboxydextran (FeraSpin™ R), as well as iron oxyhydroxide nanoparticles (IOHNPs) coated with sucrose (Venofer®), or iron salts (ferric ammonium citrate -FAC), to treat and/or prevent SARS-CoV-2 infection. At non-cytotoxic doses, IONPs and IOHNPs impaired virus replication and transcription, and the production of infectious viruses in vitro, either when the cells were treated prior to or after infection, although with different efficiencies. Moreover, our data suggest that SARS-CoV-2 infection affects the expression of genes involved in cellular iron metabolism. Furthermore, the treatment of cells with IONPs and IOHNPs affects oxidative stress and iron metabolism to different extents, likely influencing virus replication and production. Interestingly, some of the nanoparticles used in this work have already been approved for their use in humans as anti-anemic treatments, such as the IOHNP Venofer®, and as contrast agents for magnetic resonance imaging in small animals like mice, such as the FeraSpin™ R IONP. Conclusions Therefore, our results suggest that IONPs and IOHNPs may be repurposed to be used as prophylactic or therapeutic treatments in order to combat SARS-CoV-2 infection., This work was supported by the following Grants: CSIC-COV19-012/012202020E154 funded by the Spanish National Research Council Interdisciplinary Thematic Platform (PTI) Global Health (PTI Salud Global), SGL2103021 funded by the European Commission-NextGenerationEU (Regulation EU2020/2094) through CSIC’s Global Health Platform (PTI Salud Global); PDC2021-120759-100 funded by MCIN/AEI/10. 13039/50110 00110 33 and by the “European Union NextGenerationEU/PRTR”, PID2020-112685RB-100 funded by MCIN/AEI/10. 13039/50110 00110 33, and the “Atracción de Talento Investigador” programme (2017-T1/BMD-5155) funded by the “Comunidad de Madrid”. Y. Portilla was first a predoctoral FPU scholar (FPU15/06170) funded by MCIN/AEI/10. 13039/50110 00110 33 and by “ESF Investing in your future”, then a predoctoral scholar funded by CSIC-COV19-012/012202020E154 and is now a postdoctoral scholar funded by the European Commission-NextGenerationEU (Regulation EU2020/2094) through the CSIC’s Global Health Platform (PTI Salud Global, SGL2103021). D. López-García received a JAE-INTRO 2020 Fellowship from the Spanish National Research Council (CSIC, JAEINT-20-01805). V. Mulens-Arias was a postdoctoral scholar working under a Juan de La Cierva-Incorporación Contract (IJCI-2017-31447) funded by MCIN/AEI/10. 13039/50110 00110 33. N. Daviu is a predoctoral scholar (FPU18/04828) funded by MCIN/AEI/10. 13039/50110 00110 33 and by “ESF Investing in your future”. This research work was performed in the framework of the Nanomedicine CSIC HUB (ref. 202180E048)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Different coatings on magnetic nanoparticles dictate their degradation kinetics in vivo for 15 months after intravenous administration in mice

  • Portilla, Yadileiny
  • Fernández-Afonso, Yilian
  • Pérez-Yagüe, Sonia
  • Mulens-Arias, Vladimir
  • Morales, María Del Puerto
  • Gutiérrez, Lucía
  • Barber, Domingo F.
[Background] The surface coating of iron oxide magnetic nanoparticle (MNPs) drives their intracellular trafficking and degradation in endolysosomes, as well as dictating other cellular outcomes. As such, we assessed whether MNP coatings might influence their biodistribution, their accumulation in certain organs and their turnover therein, processes that must be understood in vivo to optimize the design of nanoformulations for specific therapeutic/diagnostic needs., [Results] In this study, three different MNP coatings were analyzed, each conferring the identical 12 nm iron oxide cores with different physicochemical characteristics: 3-aminopropyl-triethoxysilane (APS), dextran (DEX), and dimercaptosuccinic acid (DMSA). When the biodistribution of these MNPs was analyzed in C57BL/6 mice, they all mainly accumulated in the spleen and liver one week after administration. The coating influenced the proportion of the MNPs in each organ, with more APS-MNPs accumulating in the spleen and more DMSA-MNPs accumulating in the liver, remaining there until they were fully degraded. The changes in the physicochemical properties of the MNPs (core size and magnetic properties) was also assessed during their intracellular degradation when internalized by two murine macrophage cell lines. The decrease in the size of the MNPs iron core was influenced by their coating and the organ in which they accumulated. Finally, MNP degradation was analyzed in the liver and spleen of C57BL/6 mice from 7 days to 15 months after the last intravenous MNP administration., [Conclusions] The MNPs degraded at different rates depending on the organ and their coating, the former representing the feature that was fundamental in determining the time they persisted. In the liver, the rate of degradation was similar for all three coatings, and it was faster than in the spleen. This information regarding the influence of coatings on the in vivo degradation of MNPs will help to choose the best coating for each biomedical application depending on the specific clinical requirements., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature., This work was supported by the following grants: Grant SAF2017-82223-R (to DF Barber) funded by MCIN/AEI/10.13039/501100011033 and by ERDF a way of making Europe; Grant PID2020-112685RB-100 (to DF Barber) funded by MCIN/AEI/10.13039/501100011033; Grant PGC2018-096016-B-I00 (to L.Gutierrez) funded by MCIN/AEI/10.13039/501100011033 and by ERDF a way of making Europe. V. Mulens-Arias was a postdoctoral scholar working under a Juan de La Cierva-Incorporación Contract (IJCI-2017–31447, funded by MCIN/AEI/10.13039/501100011033) and Y. Portilla received a predoctoral FPU grant (FPU15/06170 funded by MCIN/AEI/10.13039/501100011033 and the ESF Investing in your future). Y. Fernández-Afonso thanks the Santander-Universidad Zaragoza Fellowship program for funding her PhD position. This research work was performed in the framework of the Nanomedicine CSIC HUB (ref 202180E048)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Helios as a Potential Biomarker in Systemic Lupus Erythematosus and New Therapies Based on Immunosuppressive Cells

  • París-Muñoz, Andrés
  • León-Triana, Odelaisy
  • Pérez-Martínez, Antonio
  • Barber, Domingo F.
The Helios protein (encoded by the IKZF2 gene) is a member of the Ikaros transcription family and it has recently been proposed as a promising biomarker for systemic lupus erythematosus (SLE) disease progression in both mouse models and patients. Helios is beginning to be studied extensively for its influence on the T regulatory (Treg) compartment, both CD4+ Tregs and KIR+/Ly49+ CD8+ Tregs, with alterations to the number and function of these cells correlated to the autoimmune phenomenon. This review analyzes the most recent research on Helios expression in relation to the main immune cell populations and its role in SLE immune homeostasis, specifically focusing on the interaction between T cells and tolerogenic dendritic cells (tolDCs). This information could be potentially useful in the design of new therapies, with a particular focus on transfer therapies using immunosuppressive cells. Finally, we will discuss the possibility of using nanotechnology for magnetic targeting to overcome some of the obstacles related to these therapeutic approaches., This work was supported by the grant PID2020-112685RB-100 funded by MCIN/AEI/10.13039/501100011033 (to D.F. Barber). A. París-Muñoz was a predoctoral fellow at the CNB-CSIC, supported by a fellowship from “la Caixa” Foundation (ID 100010434, fellowship code LCF/BQ/DE18/11670013), and is now a postdoctoral fellow at IdiPAZ and CNIO supported by “Progama Investigo” funded by NextGenerationEU., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

An electrostatically conjugated-functional MNK1 aptamer reverts the intrinsic antitumor effect of polyethyleneimine-coated iron oxide nanoparticles in vivo in a human triple-negative cancer xenograft

  • Mulens-Arias, Vladimir
  • Portilla, Yadileiny
  • Pérez-Yagüe, Sonia
  • Ferreras-Martín, Raquel
  • Martín, M. Elena
  • González, Victor M.
  • Barber, Domingo F.
Material suplementario en: https://doi.org/10.1186/s12645‐023‐00204‐8., Background: Triple-negative breast cancer (TNBC) remains a difficult breast cancer subtype to treat as it exhibits a particularly aggressive behavior. The dysregulation of distinct signaling pathways underlies this aggressive behavior, with an overactivation of MAP kinase interacting kinases (MNKs) promoting tumor cell behavior, and driving proliferation and migration. Therefore, MNK1 is an excellent target to impair the progression of TNBC and indeed, an MNK1-specific aptamer has proved to be efficient in inhibiting TBNC cell proliferation in vitro. Although polyethyleneimine-coated iron oxide nanoparticles (PEI–IONPs) have been used as transfection and immunomodulating agents, no study has yet addressed the benefits of using these nanoparticles as a magnetic carrier for the delivery of a functional aptamer. Results: Here, we tested the antitumor effect of a PEI–IONP complexed to the functional MNK1b-specific aptamer in vitro and in vivo. We demonstrated that these apMNKQ2@PEI–IONP nanoconjugates delivered three times more apMNKQ2 to MDA-MB-231 cells than the aptamer alone, and that this enhanced intracellular delivery of the aptamer had consequences for MNK1 signaling, reducing the amount of MNK1 and its target the phospho(Ser209)-eukaryotic initiation factor 4E (eIF4E). As a result, a synergistic effect of the apMNKQ2 and PEI–IONPs was observed that inhibited MDA-MB-231 cell migration, probably in association with an increase in the serum and glucocorticoid-regulated kinase-1 (SGK1) and the phospho(Thr346)-N-myc down-regulated gene 1 (NDRG1). However, intravenous administration of the apMNKQ2 alone did not significantly impair tumor growth in vivo, whereas the PEI–IONP alone did significantly inhibit tumor growth. Significantly, tumor growth was not inhibited when the apMNKQ2@PEI–IONP nanocomplex was administered, possibly due to fewer IONPs accumulating in the tumor. This apMNKQ2-induced reversion of the intrinsic antitumor effect of the PEI–IONPs was abolished when an external magnetic field was applied at the tumor site, promoting IONP accumulation. Conclusions: Electrostatic conjugation of the apMNKQ2 aptamer with PEI–IONPs impedes the accumulation of the latter in tumors, which appears to be necessary for PEI–IONPs to exert their antitumor activity. Graphical Abstract: [Figure not available: see fulltext.], This study was supported by the DTS18/00029 Grant (to VM Gonzalez and DF Barber) from the Instituto de Salud Carlos III (Plan Estatal de I + D + I 2017–2020), co‐financed by the European Development Regional Fund ‘‘A way to achieve Europe’’ (ERDF), and by the PID2020‐112685RB‐100 Grant (to DF Barber) funded by MCIN/AEI/10.13039/501100011033. V. Mulens‐Arias was a postdoctoral scholar working under a Juan de La Cierva‐Incorporación Contract (IJCI‐2017‐31447, funded by MCIN/AEI/10.13039/501100011033) and Y. Portilla received a predoctoral FPU Grant (FPU15/06170 funded by MCIN/AEI/10.13039/501100011033 and the ESF Investing in your future). This research work was performed in the framework of the Nanomedicine CSIC HUB and Cancer CSIC HUB., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cubic Mesocrystal Magnetic Iron Oxide Nanoparticle Formation by Oriented Aggregation of Cubes in Organic Media: A Rational Design to Enhance the Magnetic Hyperthermia Efficiency

  • Egea-Benavente, David
  • Díaz-Ufano, Carlos
  • Gallo-Cordova, Álvaro
  • Palomares, F. Javier
  • Cuya Huaman, Jhon Lehman
  • Barber, Domingo F.
  • Morales, María Del Puerto
  • Balachandran, Jeyadevan
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsami.3c03254, Magnetic iron oxide mesocrystals have been reported to exhibit collective magnetic properties and consequently enhanced heating capabilities under alternating magnetic fields. However, there is no universal mechanism to fully explain the formation pathway that determines the particle diameter, crystal size, and shape of these mesocrystals and their evolution along with the reaction. In this work, we have analyzed the formation of cubic magnetic iron oxide mesocrystals by thermal decomposition in organic media. We have observed that a nonclassical pathway leads to mesocrystals via the attachment of crystallographically aligned primary cubic particles and grows through sintering with time to achieve a sizable single crystal. In this case, the solvent 1-octadecene and the surfactant agent biphenyl-4-carboxylic acid seem to be the key parameters to form cubic mesocrystals as intermediates of the reaction in the presence of oleic acid. Interestingly, the magnetic properties and hyperthermia efficiency of the aqueous suspensions strongly depend on the degree of aggregation of the cores forming the final particle. The highest saturation magnetization and specific absorption rate values were found for the less aggregated mesocrystals. Thus, these cubic magnetic iron oxide mesocrystals stand out as an excellent alternative for biomedical applications with their enhanced magnetic properties., D.E.-B. is a predoctoral fellow supported by the Spanish Ministry of Science and Innovation through the FPI Contract (PRE2018-084189) at the Molecular Biosciences Program of the Universidad Autónoma de Madrid. This work was supported in part by the Spanish Ministry of Science and Innovation through grants SAF-2017-82223-R (to D.F.B., funded by MCIN/AEI/10.13039/501100011033 and by the ERDF a way of making Europe) and PID-2020-112685RB-I00 (to D.F.B., funded by MCIN/AEI/10.13039/501100011033) and PID2020-113480RB-I00 (to M.P.M.). F.J.P. acknowledges financial support from grant PID2021-126169OB-I00 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. The groups of D.F.B. and M.P.M. are part of the Network “Nanotechnology in Translational Hyperthermia” (HIPERNANO, RED2018-102626-T) sup- ported by the Spanish Ministry of Science and Innovation., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

DMSA-coated IONPs trigger oxidative stress, mitochondrial metabolic reprograming and changes in mitochondrial disposition, hindering cell cycle progression of cancer cells

  • Daviu, Neus
  • Portilla, Yadileiny
  • Gómez de Cedrón, Marta
  • Ramírez de Molina, Ana
  • Barber, Domingo F.
There is increasing interest in modulating the redox homeostasis of tumors since high levels of reactive oxygen species (ROS) make them more vulnerable to changes in these species. Nanomedicine offers promise in this context as such applications may provoke biological responses that induce ROS production. Indeed, iron oxide nanoparticles (IONPs) can induce ROS accumulation through the so-called Fenton reaction of iron, further augmenting the ROS in tumors and overloading the antioxidant system beyond its capacity, thereby driving oxidative stress to a level that is incompatible with cell survival. Here, three different coatings for IONPs were compared to assess their intrinsic capacity to induce ROS production in cells. Of these coatings, dimercaptosuccinic acid-coated IONPs (DMSA-NPs) provoked the strongest ROS production, which was associated with the ability to reprogram the metabolism of cancer cells. This latter phenomenon involved shutting-down oxidative phosphorylation (OXPHOS), shifting mitochondrial morphology towards a more elongated phenotype, reducing the total mitochondrial mass and ultimately, blocking cell proliferation by inducing G0/G1 cell cycle arrest. Consequently, the data obtained highlights the importance of studying the chemical properties of IONPs, presenting DMSA-NPs as a novel tool to induce oxidative stress in cancer cells and alter their cell fate., This work was supported by the grant to DF Barber funded by the MCIN/AEI/ 10.13039/501100011033 [PID2020-112685RB-100] . N. Daviu is a predoctoral scholar [FPU18/04828] funded by MCIN/AEI/ 10.13039/501100011033 and by “ESF Investing in your future”. Y. Portilla first received a predoctoral FPU scholarship [FPU15/06170] funded by MCIN/AEI/ 10.13039/501100011033 and by “ESF Investing in your future”, then a predoctoral scholarship funded by CSIC–COV19 Intramural Program [ COV19-012/012202020E154] and finally, a postdoctoral scholarship funded by the European Commission-NextGenerationEU (Regulation EU2020/2094) through the CSIC's Global Health Platform PTI [Salud Global, SGL2103021]. This work was also supported by ARM: Synergistic Projects Community of Madrid [NUTRISION-CM/Y2020/BIO-6350]; Ministerio de Ciencia e Innovación, Spain [PID2019-110183RB-C21]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Interaction of Iron Oxide Nanoparticles with Macrophages Is Influenced Distinctly by "Self" and "Non-Self" Biological Identities

  • Portilla, Yadileiny
  • Mulens-Arias, Vladimir
  • Daviu, Neus
  • Paradela, Alberto
  • Pérez-Yagüe, Sonia
  • Barber, Domingo F.
Upon contact with biological fluids like serum, a protein corona (PC) complex forms on iron oxide nanoparticles (IONPs) in physiological environments and the proteins it contains influence how IONPs act in biological systems. Although the biological identity of PC-IONP complexes has often been studied in vitro and in vivo, there have been inconsistent results due to the differences in the animal of origin, the type of biological fluid, and the physicochemical properties of the IONPs. Here, we identified differences in the PC composition when it was derived from the sera of three species (bovine, murine, or human) and deposited on IONPs with similar core diameters but with different coatings [dimercaptosuccinic acid (DMSA), dextran (DEX), or 3-aminopropyl triethoxysilane (APS)], and we assessed how these differences influenced their effects on macrophages. We performed a comparative proteomic analysis to identify common proteins from the three sera that adsorb to each IONP coating and the 10 most strongly represented proteins in PCs. We demonstrated that the PC composition is dependent on the origin of the serum rather than the nature of the coating. The PC composition critically affects the interaction of IONPs with macrophages in self- or non-self identity models, influencing the activation and polarization of macrophages. However, such effects were more consistent for DMSA-IONPs. As such, a self biological identity of IONPs promotes the activation and M2 polarization of murine macrophages, while a non-self biological identity favors M1 polarization, producing larger quantities of ROS. In a human context, we observed the opposite effect, whereby a self biological identity of DMSA-IONPs promotes a mixed M1/M2 polarization with an increase in ROS production. Conversely, a non-self biological identity of IONPs provides nanoparticles with a stealthy character as no clear effects on human macrophages were evident. Thus, the biological identity of IONPs profoundly affects their interaction with macrophages, ultimately defining their biological impact on the immune system., This work was supported by the following grants: Grant SAF2017-82223-R (to D.F.B.) funded by MCIN/AEI/ 10.13039/501100011033; and an ERDF a way of making Europe and Grant PID2020-112685RB-100 (to D.F.B.) funded by the MCIN/AEI/10.13039/501100011033. V.M.- A. was a postdoctoral scholar working under a Juan de La Cierva-Incorporación Contract (IJCI-2017-31447, funded by MCIN/AEI/10.13039/501100011033), and Y. P. was first a predoctoral FPU scholar (FPU15/06170) funded by MCIN/ AEI/10.13039/501100011033 and by “ESF Investing in your future”, then a predoctoral scholar funded by CSIC-COV19- 012/012202020E154 intramural project and finally a postdoctoral scholar funded by the European Commission- NextGenerationEU (Regulation EU2020/2094) through the CSIC’s Global Health Platform (PTI Salud Global, SGL2103021). This research work was performed in the framework of the Nanomedicine CSIC HUB (ref 202180E048)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Enhancing magnetic hyperthermia at the cell membrane by anchoring 92R-functionalized magnetic nanoparticles to low-endocytic CCR9 surface receptors

  • Egea-Benavente, David
  • Corraliza-Gorjón, Isabel
  • Zanten, Thomas S. van
  • Morales, María Del Puerto
  • Kremer, Leonor
  • Barber, Domingo F.
The data that support the findings of this study are available from the corresponding author upon reasonable request., Magnetic hyperthermia therapy (MHT) is a promising cancer treatment that has demonstrated efficacy in phase I and II clinical trials for glioblastoma and prostate cancer. MHT relies on heat generated by magnetic nanoparticles (MNPs) when exposed to alternating magnetic fields (AMFs). The heat output depends not only on the intrinsic properties of MNPs but also on extrinsic factors such as the extracellular and intracellular environments. Aggregation of MNPs under certain conditions can significantly reduce therapeutic efficiency. To overcome this limitation, we present a strategy to enhance MHT by modulating MNP-cell interactions. We functionalized dimercaptosuccinic acid (DMSA)-coated MNPs with the 92R antibody (DMSA-MNPs@92R), which selectively binds to the low-internalization chemokine receptor CCR9, overexpressed in certain tumors. Exposure of CCR9+ MOLT-4 cells to DMSA-MNPs@92R under AMFs resulted in enhanced tumor cell death. Our approach enables spatially controlled binding, maintaining MNPs in a less-aggregated state and at an optimal distance from the cell membrane to maximize heat generation. Mechanistic analysis confirmed that cytotoxicity is driven by localized hyperthermia at the subcellular level rather than a macroscopic temperature increase. These findings underscore the potential of controlled MNPs-cell interactions to improve in vitro MHT performance and open an interesting avenue for enhancing therapeutic efficacy., D.E.-B. is a predoctoral fellow at the Molecular Biosciences Program of the Universidad Autónoma de Madrid supported by the Spanish Ministry of Science and Innovation through a FPI Contract (PRE2018-084189). This work was supported in part by the Spanish Ministry of Science and Innovation through Grant SAF-2017-82223-R (to D.F.B., funded by MCIN/AEI/10.13039/501100011033 and by the ERDF a way of making Europe), PID2019-105404RB-I00 (to L.K., funded by MCIN/AEI/10.13039/501100011033), PID-2020-112685RB-I00 (to D.F.B., funded by MCIN/AEI/10.13039/501100011033), PID2023-150170OB-I00 (to M.P.M., funded by MCIN/AEI/10.13039/501100011033), and PID-2023-146212OB-I00 (to D.F.B, funded by MCIN/AEI/10.13039/501100011033 and by the ERDF, EU). This work was also supported by the CSIC Grant PIE-202320E096 (to L.K.). T.S.v.Z. acknowledges the Severo Ochoa Program for Centres of Excellence, Grant CEX2023-001286-S funded by MICIU/AEI/10.13039/501100011033. The Centro Nacional de Biotecnología (CNB-CSIC) a Severo Ochoa Center of Excellence (CEX2023-001386-S) funded by MICIU/AEI /10.13039/501100011033. The groups of D.F.B. and M.P.M. are part of the “Nanotechnology in Translational Hyperthermia” Network supported by the Spanish Ministry of Science and Innovation (HIPERNANO, RED2018-102626-T, funded by MCIN/AEI/10.13039/501100011033). This research work was performed in the framework of the Nanomedicine CSIC HUB and the CSIC Cancer HUB., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2023-001286-S)., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2023-001386-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Oxidative stress induced by DMSA-IONPs impairs breast cancer cell migration and paracrine cell communication

  • Daviu, Neus
  • Graciano-Casero, Carla
  • Barber, Domingo F.
The migration of tumor cells requires a complex interplay of these cells with their microenvironment. Significantly, these migrating (metastatic) cells undergo metabolic and oxidative changes that render them more sensitive to shifts in their redox homeostasis. Nanoparticle (NP)-based pro-oxidant therapies are strategies that can potentially influence cell viability and migration. Among these, iron oxide NPs (IONPs) stand out due to their biocompatibility and the fact they induce ROS production through the Fenton Reaction. Here we investigate the possibility of using dimercaptosuccinic acid (DMSA)-coated IONPs as therapeutic tools to combat breast cancer (BC) cell migration and metastasis, influencing the paracrine communication between tumor and endothelial cells., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This work was supported by grants to D.F. Barber: PID2020-112685RB-I00 from MCIN/AEI/10.13039/501100011033; PID2023-146212OB-I00 from MCIN/AEI/10.13039/501100011033, and by the ERDF, EU; and by the grant S2022/BMD-7321 from the Madrid Regional Government (Comunidad de Madrid). N. Daviu was first a predoctoral scholar [FPU18/04828] funded by the MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”, and she then received a predoctoral scholarship funded by the PID2020-112685RB-I00 grant and subsequently a postdoctoral scholarship funded by the PID2023-146210B-I00 grant. C. Graciano-Casero was a master’s thesis student on the Clinical Biotechnology Master’s Degree course of the European University of Madrid. This research work was performed in the framework of the Nanomedicine CSIC HUB and the Cancer CSIC HUB. The Centro Nacional de Biotecnología (CNB-CSIC) is a Severo Ochoa Center of Excellence (CEX2023-001386-S) funded by MCIN/AEI/10.13039/501100011033., Peer reviewed, Modelo experimental alternativo-NAM, in vitro - Tipos celulares
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Endolysosomal remodeling and acidity dictates ferroptosis sensitivity to iron oxide nanoparticles

  • Daviu, Neus
  • Irigaray-Moreno, Alberto
  • Graciano-Casero, Carla
  • Barber, Domingo F.
Iron oxide nanoparticles (IONPs) exhibit remarkable anti-tumoral activity, largely mediated by the generation of reactive oxygen species (ROS). Although certain IONPs can induce ferroptosis, the determinants underlying cell-type-specific sensitivity remain poorly understood. Here, we provide novel mechanistic insight by demonstrating that lysosomal acidity and plasticity critically regulate iron mobilization, ROS compartmentalization, and the ferroptotic response triggered by dimercaptosuccinic acid-coated IONPs (DMSA‑IONPs) in MDA‑MB‑231 breast cancer and U87MG glioma cells. DMSA-IONPs generate ROS in both cell models, however, their subcellular localization markedly differed. In MDA-MB-231 cells, highly acidic lysosomes retained redox-active iron (Fe2+), leading to localized ROS accumulation, lysosomal enlargement and pronounced lipid peroxidation, ultimately inducing ferroptosis, which was reverted by the anti-ferroptosis drug Ferrostatin-1. In contrast, the less acidic lysosomes of U87MG cells released iron into the cytosol and mitochondria, resulting in diffuse ROS production without lipid peroxidation and conferring resistance to ferroptosis despite higher nanoparticle uptake. While IONP‑mediated ROS generation via iron mobilization and Fenton‑like reactions is well established, our findings identify lysosomes as critical determinants of cellular responses to IONPs exposure. Specifically, lysosomal acidity and endolysosomal trafficking govern ferroptotic sensitivity to IONPs by controlling the site of ROS accumulation. Our results demonstrate that IONP-induced ferroptosis depends not only on total ROS levels but also on ROS subcellular distribution, with ROS accumulated in lysosomes triggering lipid peroxidation of these organelles. These insights highlight the importance of evaluating lysosomal physiology across tumor type to optimize nanoparticle-based ferroptosis therapies, particularly for tumors resistant to apoptosis., This work was supported by grants to D.F. Barber: PID2020–112685RB-I00 from MCIN/AEI/10.13039/501100011033; PID2023–146210B-I00 from MCIN/AEI/10.13039/501100011033, and by the ERDF, EU; and S2022/BMD−7321 from the Madrid Regional Government (Comunidad de Madrid). N. Daviu was first a predoctoral scholar [FPU18/04828] funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”, and she then received a predoctoral scholarship funded by the PID2020–112685RB-I00 grant and subsequently a postdoctoral scholarship funded by the PID2023–146210B-I00 grant. A. Irigaray-Moreno was first a master's thesis student of the Biomolecules and Cell Dynamics Masters course at the Universidad Autónoma de Madrid, and he was then awarded a JAE-Intro ICU scholarship (JAEICU_24_00026) by the Nanomedicine CSIC HUB. C. Graciano-Casero was a master's thesis student on the Clinical Biotechnology Master's Degree of the European University of Madrid. This research work was performed in the framework of the Nanomedicine CSIC HUB and the Cancer CSIC HUB. The Centro Nacional de Biotecnología (CNB-CSIC) is a Severo Ochoa Center of Excellence (CEX2023–001386-S) funded by MICIU/AEI /10.13039/501100011033., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2023–001386-S)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Different coatings on magnetic nanoparticles dictate their degradation kinetics in vivo for 15 months after intravenous administration in mice

  • Portilla, Y.
  • Fernández-Afonso, Y.
  • Pérez-Yagüe, S.
  • Mulens-Arias, V.
  • Morales, M. P.
  • Gutiérrez, L.
  • Barber, D. F.
Background: The surface coating of iron oxide magnetic nanoparticle (MNPs) drives their intracellular trafficking and degradation in endolysosomes, as well as dictating other cellular outcomes. As such, we assessed whether MNP coatings might influence their biodistribution, their accumulation in certain organs and their turnover therein, processes that must be understood in vivo to optimize the design of nanoformulations for specific therapeutic/diagnostic needs. Results: In this study, three different MNP coatings were analyzed, each conferring the identical 12 nm iron oxide cores with different physicochemical characteristics: 3-aminopropyl-triethoxysilane (APS), dextran (DEX), and dimercaptosuccinic acid (DMSA). When the biodistribution of these MNPs was analyzed in C57BL/6 mice, they all mainly accumulated in the spleen and liver one week after administration. The coating influenced the proportion of the MNPs in each organ, with more APS-MNPs accumulating in the spleen and more DMSA-MNPs accumulating in the liver, remaining there until they were fully degraded. The changes in the physicochemical properties of the MNPs (core size and magnetic properties) was also assessed during their intracellular degradation when internalized by two murine macrophage cell lines. The decrease in the size of the MNPs iron core was influenced by their coating and the organ in which they accumulated. Finally, MNP degradation was analyzed in the liver and spleen of C57BL/6 mice from 7 days to 15 months after the last intravenous MNP administration. Conclusions: The MNPs degraded at different rates depending on the organ and their coating, the former representing the feature that was fundamental in determining the time they persisted. In the liver, the rate of degradation was similar for all three coatings, and it was faster than in the spleen. This information regarding the influence of coatings on the in vivo degradation of MNPs will help to choose the best coating for each biomedical application depending on the specific clinical requirements.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Enhancing Magnetic Hyperthermia at the Cell Membrane by Anchoring 92R‐Functionalized Magnetic Nanoparticles to Low‐Endocytic CCR9 Surface Receptors

  • Egea-Benavente, David
  • Corraliza-Gorjón, Isabel
  • Van Zanten, Thomas S.
  • Morales, María del Puerto
  • Kremer, Leonor
  • Barber, Domingo F.
Magnetic hyperthermia therapy (MHT) is a promising cancer treatment that has demonstrated efficacy in phase I and II clinical trials for glioblastoma and prostate cancer. MHT relies on heat generated by magnetic nanoparticles (MNPs) when exposed to alternating magnetic fields (AMFs). The heat output depends not only on the intrinsic properties of MNPs but also on extrinsic factors such as the extracellular and intracellular environments. Aggregation of MNPs under certain conditions can significantly reduce therapeutic efficiency. To overcome this limitation, we present a strategy to enhance MHT by modulating MNP-cell interactions. We functionalized dimercaptosuccinic acid (DMSA)-coated MNPs with the 92R antibody (DMSA–MNPs@92R), which selectively binds to the low-internalization chemokine receptor CCR9, overexpressed in certain tumors. Exposure of CCR9+ MOLT-4 cells to DMSA–MNPs@92R under AMFs resulted in enhanced tumor cell death. Our approach enables spatially controlled binding, maintaining MNPs in a less-aggregated state and at an optimal distance from the cell membrane to maximize heat generation. Mechanistic analysis confirmed that cytotoxicity is driven by localized hyperthermia at the subcellular level rather than a macroscopic temperature increase. These findings underscore the potential of controlled MNPs-cell interactions to improve in vitro MHT performance and open an interesting avenue for enhancing therapeutic efficacy.